Ci Investments Inc. Neurocrine Biosciences Inc Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ci Investments Inc. holds 3,546 shares of NBIX stock, worth $480,199. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,546

Previous 2,667 32.96%

Holding current value

$480,199

Previous $367,000 11.44%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $100,715 - $134,618	879 Added 32.96%	3,546 $409,000
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $3,794 - $4,152	29 Added 1.1%	2,667 $367,000
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $153,089 - $168,750	1,174 Added 80.19%	2,638 $364,000
Q4 2023 Feb 12, 2024	SELL	$106.07 - $132.76 $28,638 - $35,845	-270 Reduced 15.57%	1,464 $193,000
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $22,940 - $28,572	-244 Reduced 12.34%	1,734 $195,000
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $102,064 - $119,551	1,140 Added 136.04%	1,978 $187,000
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $65,594 - $85,744	697 Added 494.33%	838 $85,000
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $92 - $107	-1 Reduced 0.7%	141 $15,000
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $25,162 - $33,223	-332 Reduced 70.04%	142 $14,000
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $2,028 - $2,654	-28 Reduced 5.58%	474 $44,000
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $7,487 - $9,984	94 Added 23.04%	502 $43,000
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $35,161 - $40,404	408 New	408 $39,000
Q3 2020 Nov 09, 2020	SELL	$96.16 - $135.15 $342,810 - $481,809	-3,565 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$85.09 - $130.36 $303,345 - $464,733	3,565 New	3,565 $435,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Neurocrine Biosciences Inc Transaction History